Bipolarity
Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
CompletedNCT06462612
What is this study about?Researchers compared Lumateperone and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.
This study has finished and is no longer accepting participants.
Multiple locations, including BentonvilleBipolarityMedication studyAges 18–75
- Countries
- United States, Bulgaria, Romania, + 1 other
- Sponsor
- Intra-Cellular Therapies, Inc.
RecruitingNCT07573839
Official study titleAn Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Using Sentiment Analysis Technology Based on Multi-modal Feature Fusion
In ShanghaiBipolarityObservational studyAges 18–64
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
RecruitingNCT06059313
About this title
Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders
Read the official source — NCT06059313Official study titleRelationship Between Premorbid Personality Traits and Cognitive and Behavioral Disorders
In NantesBipolarityObservational studyAges 18+
- Countries
- France
- Sponsor
- Nantes University Hospital
RecruitingNCT07167563
About this title
Real-world Lithium Intake
Read the official source — NCT07167563Official study titleReal-world Lithium Intake Measured by a Pillbox: A Clinical Study to Test Real-world Compliance With Lithium Treatment
In AarhusBipolarityObservational studyAges 18+
- Countries
- Denmark
- Sponsor
- University of Aarhus
Not Yet RecruitingNCT07654348
Official study titleThe Efficacy and Mechanism of Different Intervention Strategy for Bipolar II Disorder Patients With Rhythm Disturbance
This study isn't recruiting yet.
In HangzhouBipolarityMedication studyAges 18–60
- Countries
- China
- Sponsor
- First Affiliated Hospital of Zhejiang University
Not Yet RecruitingNCT07570875
Official study titleEvaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolar Disorder in A Rural Southern Catchment Area - A Four-Arm Pilot Study
This study isn't recruiting yet.
In MontgomeryBipolarityInterventional studyAges 18+
- Countries
- United States
- Sponsor
- University of Alabama at Birmingham
UnknownNCT06608641
Official study titleA Double-blind, Oral, Multiple-dose, Parallel, Randomized Study to Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients With Acute Mania Episodes With or Without Mixed Features
Current recruitment status is unconfirmed.
Multiple locations, including CerritosBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Jina Pharmaceuticals Inc.
CompletedNCT07046494
What is this study about?Researchers compared RAP-219 and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Rapport Therapeutics Inc.
RecruitingNCT07589647
Official study titleResearch on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disordercomorbid With Obesity
In HangzhouBipolarityPlacebo comparisonAges 18–45
- Countries
- China
- Sponsor
- First Affiliated Hospital of Zhejiang University
RecruitingNCT07622927
Official study titleA Data-Driven Approach to Early Mental Health Screening in Offspring of Parents With Bipolar Disorder
In DallasBipolarityObservational studyAges 7+
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
WithdrawnNCT01932541
What is this study about?Researchers are studying Latuda (Lurasidone) to find out how it affects manic symptoms in children and adolescents with bipolarity type II during a manic episode.
This study was withdrawn before enrollment.
In BostonBipolarityMedication studyAges 6–17
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
UnknownNCT05891639
Official study titleInvestigating Factors Affecting Clinical Trial Participation Rates in Patients With Bipolar Disorder
Current recruitment status is unconfirmed.
In San FranciscoBipolarityObservational studyAges 18+
- Countries
- United States
- Sponsor
- Power Life Sciences Inc.